Mechanisms of estrogenic protection against gp120-induced neurotoxicity.

Abstract

gp120, an HIV coat glycoprotein that may play a role in AIDS-related dementia complex (ADC), induces neuronal toxicity characterized by NMDA receptor activation, accumulation of intracellular calcium, and downstream degenerative events including generation of reactive oxygen species and lipid peroxidation. We have previously demonstrated estrogenic protection against gp120 neurotoxicity in primary hippocampal cultures. We here characterize the mechanism of protection by blocking the classical cytosolic estrogen receptors and by measuring oxidative end points including accumulation of extracellular superoxide and lipid peroxidation. Despite blocking ERalpha and ERbeta with 1 microM tamoxifen, we do not see a decrease in the protection afforded by 100 nM 17 beta-estradiol against 200 pM gp120. Additionally, 17alpha-estradiol, which does not activate estrogen receptors, protects to the same extent as 17beta-estradiol. 17beta-Estradiol does, however, decrease gp120-induced lipid peroxidation and accumulation of superoxide. Together the data suggest an antioxidant mechanism of estrogen protection that is independent of receptor binding.

• Authors: S A Howard, S M Brooke, R M Sapolsky
• Journal: Experimental neurology (Exp Neurol) Vol. 168 Issue 2 Pg. 385-91 (Apr 2001) ISSN: 0014-4886 [Print] United States
• PMID: 11259126 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Estrogen Antagonists
• HIV Envelope Protein gp120
• Receptors, Estrogen
• Tamoxifen
• Superoxides
• Estradiol

Topics

• Animals
• Cells, Cultured
• Embryo, Mammalian
• Estradiol (pharmacology)
• Estrogen Antagonists (pharmacology)
• HIV Envelope Protein gp120 (toxicity)
• Hippocampus
• Lipid Peroxidation (drug effects, physiology)
• Rats
• Rats, Sprague-Dawley
• Receptors, Estrogen (drug effects, physiology)
• Superoxides (metabolism)
• Tamoxifen (pharmacology)